Pipeline? Every biotech has a pipeline.
Buy late stage biotechs or those with approved products like GTHP.
FDA approval expected any day.
The Hep C market is huge.
Some 60M pap mer tests are taken annually in the US.
GTHP's biophothonic scan is noninvasive, more accurate and produces instant test results.
Profit margins on the disposable used in each scan are 90%.
It's already approved in EU, Canada, Mexico.
International sales are ramping up.
Somebody wanted to unload a boat load of shares.
The overpriced shares are being distributed to gullible saps.
An innovative product for a big market at a current market cap of only $20M.
EXAS, which recently got its colorectal cancer scan approved, saw its stock soar to a $2 BILLION market cap.
GTHP developed a biophothonic cervical cancer scan.
It's noninvasive, more accurate than pap smears and the test results are immediate.
Some 60M pap smear tests are taken in the US.
The market is huge.
TYPICAL: a biotech complete late stage trials and submits a NDA.
ATYPICAL: endless mice studies
ATYPICAL: completing a P2 trial but never starting a P3 trial.
ATYPICAL: hyping a vaccine for ebola but never starting a trial
ATYPICAL: peddling a technology that failed decades ago instead of writing it off.
$200.00 to $6.45 and two reverse splits is an unmitigated disaster.
Place you orders on the Australian Exchange and pick up shares for pennies.
Why pay $6.46 for the penny stock here?
What is ISR?
It's just common sense.
You sound like you fell for the boiler room hype and got conned into a bag.
In few weeks from now, you will wish that your were scared out of your shares, like GENE's unnecessary test scares women.
OK, you are warned that you might develop cancer.
What will you do?
And then, what will you do for the created anxiety?
What is the purpose of the test? To give patients anxiety?
OK, your momma takes the test and it shows that she has a predisposition to develop breast cancer.
How does that help her?
Will she go for chemo to treat a cancer that hasn't developed?
The only practical use of the test might be: the women who are identified by the test that they won't develop cancer won't have to take annual mammograms.